Echo Therapeutics Stock Net Income
Echo Therapeutics fundamentals help investors to digest information that contributes to Echo Therapeutics' financial success or failures. It also enables traders to predict the movement of Echo Stock. The fundamental analysis module provides a way to measure Echo Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Echo Therapeutics stock.
Echo |
Echo Therapeutics Company Net Income Analysis
Echo Therapeutics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Echo Therapeutics Net Income | (12.5 M) |
Most of Echo Therapeutics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Echo Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Echo Therapeutics reported net income of (12.5 Million). This is 103.66% lower than that of the Healthcare sector and 105.25% lower than that of the Medical Devices industry. The net income for all United States stocks is 102.19% higher than that of the company.
Echo Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Echo Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Echo Therapeutics could also be used in its relative valuation, which is a method of valuing Echo Therapeutics by comparing valuation metrics of similar companies.Echo Therapeutics is currently under evaluation in net income category among related companies.
Echo Fundamentals
| Return On Equity | -3.65 | |||
| Return On Asset | -359.77 | |||
| Current Valuation | 3.43 M | |||
| Shares Outstanding | 12 M | |||
| Number Of Shares Shorted | 273.27 K | |||
| Price To Earning | (0.03) X | |||
| Price To Book | 3.11 X | |||
| Price To Sales | 990.09 X | |||
| Revenue | 5.12 K | |||
| Gross Profit | 5.12 K | |||
| EBITDA | (5.18 M) | |||
| Net Income | (12.5 M) | |||
| Cash And Equivalents | 172.72 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 3.52 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 0.05 X | |||
| Book Value Per Share | (0.55) X | |||
| Cash Flow From Operations | (4.82 M) | |||
| Short Ratio | 3.40 X | |||
| Earnings Per Share | (1.10) X | |||
| Number Of Employees | 19 | |||
| Beta | 6.99 | |||
| Market Capitalization | 48.02 K | |||
| Total Asset | 805.09 K | |||
| Retained Earnings | (145.78 M) | |||
| Working Capital | (2.93 M) | |||
| Current Asset | 300.74 K | |||
| Current Liabilities | 3.24 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Echo Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Echo Therapeutics' short interest history, or implied volatility extrapolated from Echo Therapeutics options trading.
Pair Trading with Echo Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Echo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Echo Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Echo Stock
If you are still planning to invest in Echo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Echo Therapeutics' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |